A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature
Condition: Dwarfism Intervention: Drug: PEG-somatropin Sponsors: GeneScience Pharmaceuticals Co., Ltd.; Tongji Hospital; First Hospital of Jilin University; Affiliated Hospital of Jiangnan University; The First Affiliated Hospital with Nanjing Medical University; Shanghai Children's Hospital; The Children's Hospital of Zhejiang University School of Medicine; Children's Hospital of Fudan University Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2017 Category: Research Source Type: clinical trials
A Study of PEG-somatropin in the Treatment of Children With Idiopathic Short Stature
Condition: Dwarfism Interventions: Drug: Jintrolong® low dose group; Drug: Jintrolong® high dose group Sponsors: GeneScience Pharmaceuticals Co., Ltd.; Tongji Hospital; First Hospital of Jilin University; Affiliated Hospital of Jiangnan University; The First Affiliated Hospital with Nanjing Medical University; Shanghai Children's Hospital; The Children's Hospital of Zhejiang University School of Medicine; Children's Hospital of Fudan University Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2017 Category: Research Source Type: clinical trials
